Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
A global survey by the International Diabetes Federation shows that 40 % of employees with diabetes face negative treatment at work, with many considering leaving their jobs due to stigma and lack of support.
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research from the University of Cambridge.
University of Oxford and Manchester researchers found that children monitored regularly for height and weight from an early age will be less likely to experience child obesity.
Peter Robins, from Metabolic Health Solutions (MHS), describes how a new clinical management tool can help individualise treatment of obesity and Type 2 diabetes.
Pioneering women innovators have been awarded funding and business support to develop and grow their business by the UK government, echoing the innovation theme of International Women's Day 2019.
New research announced today at the Diabetes UK Professional Conference has revealed shocking health inequalities between people with Type 1 diabetes depending on where they live.
John Grumitt, CEO of Changing Health and Chair of IDEAL Group highlights the importance of tackling the biggest challenges in diabetes care – together.
Professor Graham MacGregor, Chair of Action on Sugar, discusses stopping excessive sugar consumption, whilst investigating obesity and type 2 diabetes.
Adrian Sanders, Secretary-General of The Parliamentarians for Diabetes Global Network (PDGN) reveals how organising globally, acting locally is a sound approach when it comes to tackling diabetes.
Barbara Harpham, Chair of the UK-based Medical Technology Group, explains the role that technology can play in reducing the financial and societal burden of diabetes.
